A new report from the Lancet Global Commission calls for a shift in how obesity is diagnosed, moving beyond the traditional ...

Obesity is now understood as a condition that affects the functions of organs and tissues, leading to complications such as ...

Refined carbs are carbohydrates that have gone through extensive processing that strips them of certain nutrients, such as ...

Fitness outranks weight in predicting mortality risk, as new studies show high fitness levels reduce early death risks ...

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...

The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

An international panel of researchers say the measure is too simplistic and focuses too much on weight versus wellness.

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...